Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Classical hematology 1

Conditions

Myelodysplastic Syndromes 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Acute 2Leukemia, Biphenotypic, Acute 1Leukemia 1Hematologic Diseases 1Anemia, Refractory, with Excess of Blasts 1

Interventions

venetoclax 108Azacitidine 92Cytarabine 77Specimen Handling 52fludarabine 47Biopsy 38Daunorubicin 31Cyclophosphamide 31Injections 29Decitabine 29Idarubicin 27fludarabine phosphate 25Granulocyte Colony-Stimulating Factor 22Busulfan 22Whole-Body Irradiation 20Mycophenolic Acid 20Tacrolimus 18decitabine and cedazuridine drug combination 17Melphalan 17CPX-351 17Stem Cell Transplantation 16gilteritinib 14Mitoxantrone 14ivosidenib 13Filgrastim 13Peripheral Blood Stem Cell Transplantation 12Cladribine 12Magnetic Resonance Spectroscopy 11Etoposide 11Cyclosporine 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Myeloid, Acute × cedazuridine × 90 days × Clear all
NCT04256317 2026-04-30

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Taiho Oncology, Inc.

Phase 2/3 Recruiting
316 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Hematologic Diseases, Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT05636514 2026-03-18

CELESTIAL-MDS

Clinical Hub for Interventional Research (CHOIR)

Phase 1 Recruiting
12 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡